Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-09-27FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application from Apotex Corp. for a generic amlodipine/atorvastatin combination tablet.
-
FDA approval · 2022-09-26FDA Approved: EXFORGE HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for EXFORGE HCT, a fixed-dose combination of amlodipine, valsartan, and hydrochlorothiazide. The spo…
-
FDA approval · 2022-09-26FDA Approved: NICARDIPINE HYDROCHLORIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for nicardipine hydrochloride, enabling the marketing of this generic product…
-
FDA approval · 2022-09-23FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (ScieGen Pharmaceuticals, Inc)
FDA approves ScieGen's generic diltiazem hydrochloride under an Original Application (ANDA).
-
FDA approval · 2022-09-14FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for a generic Losartan Potassium and Hydrochlorothiazide product by Lupin Pharmaceuticals.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-08-31FDA Approved: FUROSEMIDE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for furosemide from Hospira, Inc.
-
FDA approval · 2022-08-29FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for Losartan Potassium, authorizing changes to an already approved generic …
-
FDA approval · 2022-08-29FDA Approved: OLMESARTAN MEDOXOMIL — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for olmesartan medoxomil submitted by Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2022-08-26FDA Approved: CHLORTHALIDONE CHLORTHALIDONE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved an original application for a generic chlorthalidone by Alembic Pharmaceuticals Limited.
-
FDA approval · 2022-08-17FDA Approved: VALSARTAN — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
The FDA approved a supplemental application for valsartan from Jubilant Cadista Pharmaceuticals Inc. This approval indicates regulatory auth…
-
FDA approval · 2022-08-16FDA Approved: METOPROLOL SUCCINATE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' supplemental application for metoprolol succinate ER tablets.
-
FDA approval · 2022-08-08FDA Approved: LABETALOL HYDROCHLORIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved an original-application for a generic labetalol hydrochloride product from Unichem Pharmaceuticals (USA), Inc., granting approv…
-
FDA approval · 2022-08-08FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approved Slate Run Pharmaceuticals' generic diltiazem hydrochloride under an original ANDA.
-
FDA approval · 2022-08-04FDA Approved: CHLORTHALIDONE — Original Application (Lifestar Pharma LLC)
The FDA approved an original application for chlorthalidone from Lifestar Pharma LLC, a generic diuretic indicated for hypertension and edem…
-
FDA approval · 2022-07-21FDA Approved: VALSARTAN — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for VALSARTAN from Amneal Pharmaceuticals LLC.
-
FDA approval · 2022-07-19FDA Approved: PHENOXYBENZAMINE HYDROCHLORIDE — Original Application (Novitium Pharma LLC)
FDA approved the original ANDA for phenoxybenzamine hydrochloride (generic) from Novitium Pharma LLC. The product is now available as a gene…
-
FDA approval · 2022-07-14FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
FDA approved a supplemental application for Jubilant Cadista's generic Losartan Potassium and Hydrochlorothiazide product.
-
FDA approval · 2022-07-14FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for Losartan Potassium and Hydrochlorothiazide from Unichem Pharmaceuticals (USA), Inc.
-
FDA approval · 2022-07-14FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Teva's generic Losartan Potassium and Hydrochlorothiazide, expanding access to this antihype…
-
FDA approval · 2022-07-14FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Losartan Potassium by Camber Pharmaceuticals, enabling the marketing of a generic Losartan P…
-
FDA approval · 2022-07-13FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for a generic fixed-dose combination of losartan potassium and hydrochlorothiazide by NorthStar …
-
FDA approval · 2022-07-06FDA Approved: TRIAMTERENE — Original Application (Biocon Pharma Inc.)
The FDA approved Biocon Pharma Inc.'s original ANDA for Triamterene, granting generic approval to market Triamterene.
-
FDA approval · 2022-07-01FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Losartan Potassium from Aurobindo Pharma Limited, authorizing changes to the approved ANDA.
-
FDA approval · 2022-07-01FDA Approved: OLMESARTAN MEDOXOMIL — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for olmesartan medoxomil from Micro Labs Limited, granting approval of the generic product. This con…
-
FDA approval · 2022-07-01FDA Approved: OLMESARTAN MEDOXOMIL — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Olmesartan medoxomil from Macleods Pharmaceuticals Limited.